NDC 59572-775
Luspatercept
Luspatercept
Luspatercept is a Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Celgene. The primary component is Luspatercept.
| Product ID | 59572-775_0619a105-2e09-4d73-a492-8f3ad7a61ec3 |
| NDC | 59572-775 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Luspatercept |
| Generic Name | Luspatercept |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2019-11-08 |
| Marketing Category | BLA / BLA |
| Application Number | BLA761136 |
| Labeler Name | Celgene |
| Substance Name | LUSPATERCEPT |
| Active Ingredient Strength | 75 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |